Topix Pharmaceuticals, Inc Report issue

For profit Phase 4
Founded: Amityville NY United States (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2018
NCT03563365
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Topix Pharmaceuticals, Inc